Amir Nashat is Director at FATE THERAPEUTICS INC (FATE). They have made 41 open-market trades across 8 companies since 2013, most recently 2025-09-11.
CIK 0001575843
11 open-market purchases totalling $48.0M since 2013, against 30 sales. Across 10 scored buys the stock is up 1.1% at ninety days, and 2.5 points behind the S&P over the same stretch.
10 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 30% | 30% | 50% |
| Avg Move | -5.8% | -7.4% | +1.1% |
| Alpha | -6.5% | -9.7% | -2.5% |
| Scored | 10 | 10 | 10 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CAMP | BUY | 2025-09-11 | 2025-09-11 | $1.53 | $4.0M | -21.3% | +13.1% | +78.8% |
| CAMP | BUY | 2024-10-15 | 2024-10-15 | $11.00 | $10.0M | +0.4% | -13.8% | -64.6% |
| SRRK | BUY | 2022-06-22 | 2022-06-24 | $4.90 | $6.2M | +12.5% | +11.5% | +15.8% |
| MORF | SELL | 2021-05-21 | 2021-05-25 | $45.50 | $20.4M | +18.2% | +26.3% | +28.8% |
| MTCR | BUY | 2020-09-18 | 2020-09-22 | $13.00 | $3.0M | -6.0% | -15.0% | -26.3% |
| FATE | SELL | 2019-08-01 | 2019-08-02 | $22.53 | $671K | -9.8% | -14.5% | -24.6% |
| FATE | SELL | 2019-07-31 | 2019-08-02 | $22.53 | $2.8M | -9.8% | -14.5% | -24.6% |
| FATE | SELL | 2019-07-31 | 2019-08-02 | $22.53 | $677K | -9.8% | -14.5% | -24.6% |
| FATE | SELL | 2019-07-30 | 2019-07-30 | $22.51 | $2.0M | -16.8% | -23.9% | -31.8% |
| FATE | SELL | 2019-07-26 | 2019-07-30 | $22.51 | $4.7M | -16.8% | -23.9% | -31.8% |
| FATE | SELL | 2019-07-23 | 2019-07-25 | $22.51 | $3.6M | -9.7% | -22.0% | -32.5% |
| FATE | SELL | 2019-07-22 | 2019-07-22 | $22.52 | $1.1M | -5.1% | -14.3% | -35.4% |
| FATE | SELL | 2019-07-18 | 2019-07-22 | $22.52 | $2.7M | -5.1% | -14.3% | -35.4% |
| FATE | SELL | 2019-07-18 | 2019-07-22 | $22.50 | $465K | -5.1% | -14.3% | -35.4% |
| MORF | BUY | 2019-07-01 | 2019-07-01 | $15.00 | $1.9M | -16.2% | -4.0% | -23.0% |
| FATE | SELL | 2019-01-30 | 2019-02-01 | $14.16 | $1.5M | -2.9% | +6.9% | +10.4% |
| FATE | SELL | 2019-01-29 | 2019-01-31 | $14.16 | $2.7M | -0.9% | +7.0% | +7.8% |
| FATE | SELL | 2019-01-28 | 2019-01-30 | $13.78 | $1.9M | +3.7% | +12.7% | +14.4% |
| FATE | SELL | 2019-01-25 | 2019-01-29 | $14.14 | $2.5M | -2.2% | +9.2% | +21.5% |
| SELB | BUY | 2019-01-25 | 2019-01-29 | $1.50 | $1.7M | +25.9% | +19.9% | +34.9% |
| FATE | SELL | 2019-01-18 | 2019-01-23 | $16.28 | $1.3M | -3.2% | -0.6% | +16.7% |
| FATE | SELL | 2019-01-18 | 2019-01-23 | $16.28 | $620K | -3.2% | -0.6% | +16.7% |
| FATE | SELL | 2018-12-20 | 2018-12-26 | $12.25 | $410K | +48.3% | +25.1% | +45.2% |
| FATE | SELL | 2018-12-19 | 2018-12-21 | $13.41 | $2.4M | +30.9% | +31.6% | +57.3% |
| FATE | SELL | 2018-12-13 | 2018-12-17 | $16.67 | $583K | -20.6% | +9.5% | +20.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| SYRS |
| 48,320 |
| $6K |
| RCPT | 23,253 | — |
| Total | $5.1M |
Shares reported on the most recent Form 4, priced at the 2025-09-11 close. 1 holding could not be priced and is excluded from the total.